The two new studies uncover a dual role for agonist-induced phosphorylation of the R-Smad linker region. It is not only required for ubiquitin-proteasomal degradation of activated R-Smads, but it is also important for achieving their maximum transcriptional activity. The last minutes of Smads before their degradation are marked by a boost in their activity due to phosphorylation. The increased activity is likely to be important for Smad-mediated TGF-β/BMP signaling in the induction of target gene expression, neural differentiation, and tissue patterning. This scenario represents a new example of what we have learned from studying the nuclear hormone receptors, i.e., the activity of transcription factors is often, if not always, coupled to their destruction.
The two new studies stimulate many interesting questions. Gao et al. showed that TGF-β-induced phosphorylation of the Thr179 residue is critical for binding of Nedd4L. However, signaling via the epidermal growth factor and MAPK also induces Thr179 phosphorylation but cannot promote Nedd4L binding. How does the same phosphorylation event generate two such different outcomes? One explanation could be the different intracellular locales where these different phosphorylation events take place. Smurf1 and Nedd4L are closely related E3 ubiquitin ligases, both recognizing the PY motif in their substrates via their WW domain. What is the structural basis to discriminate the Smurf1-Smad1 and Nedd4L-Smad3 interactions? Why is it that C-terminaltail phosphorylation and Smad4 are both required for CDK8/9 to phosphorylate the linker region of R-Smads? Does Smad4 help to recruit CDK8/9 to their R-Smad substrates? Given that YAP and Smurf bind to the same linker phosphorylation sites, what then are the mechanisms that control the balance of these functionally opposite interactions and that mediate the switch from activation to degradation? In addition, YAP activity is regulated by Hippo signaling. It will be interesting to investigate whether there is functional convergence of the BMP and Hippo signaling pathways in the control of cell proliferation and organ size. On the other hand, although YAP is an important coactivator of Smad1 in BMP signaling, it may not be a major promoter of Smad2/3 activity. Is there, then, a counterpart to YAP that collaborates with Smad2/3? Finally, dephosphorylation of activated R-Smads by phosphatases has been shown to play an important role in terminating Smad function. As Gao et al. point out, it is still an open question which signaling turn off mechanism is used in which physiological setting. Answers to these questions will surely increase our understanding of the molecular basis of TGF-β/BMP regulation and the crosstalk between different signaling pathways.
Tissue architecture provides an environment for cells to produce and respond to signals. In order to develop into functional organs, cells expressing ligands and cells expressing receptors have to be located at the right place at the right time to establish proper signaling cascades. A recent study showed that establishment of correct epithelial polarity is essential for epithelial specification and organogenesis in the mouse mammary gland (McCaffrey and Macara, 2009 The GTPase Cdc42 specifies polarity in various biological processes. Kesavan et al. (2009) now demonstrate that Cdc42 also regulates epithelial cell polarity in the developing mouse pancreas, where it is required for tubule formation and maintenance. Furthermore, the polarization of epithelial tissue influences the differentiation of pancreatic progenitor cells, linking cell polarity to cell specification.
Cell 139, November 13, 2009 ©2009 Elsevier Inc. 661 lumenal epithelia. In addition, the Par3-depleted mammary epithelia had abnormal ductal structures, suggesting a link between tissue organization, or polarity, and the specification of cell fate. A new study by Kesavan et al. (2009) in this issue of Cell now examines the role of the polarity regulator Cdc42 in the formation of tubules in the mouse pancreas. Kesavan and colleagues report that Cdc42 initiates formation of the apical lumens that ultimately combine to form tubules, and that these epithelial structures instruct pancreatic progenitor cell differentiation and specification ( Figure  1 ). These findings establish a link between cell polarization and tissue differentiation during organ development. Cdc42, a Rho family GTPase, plays essential roles in a variety of biological processes, such as formation of the cytoskeleton, vesicle trafficking, and establishment of apical polarity. In their new work, Kesavan et al. examine the role of Cdc42 in the polarization of epithelial cells and in lumen formation in the developing pancreas. The authors first show that tubular structures in the mouse pancreas in vivo are generated through fusion of existing microlumens. Initially, clusters of polarized cells, with apical surfaces facing the lumen, form microlumens. As more cells become polarized, additional lumenal structures form, ultimately fusing into a tubular network. More specifically, the authors demonstrate that atypical protein kinase C (aPKC), a downstream effector of Cdc42, is required for the coalescence of microlumens into tubular structures. These tubular structures mature to form a single layer of polarized epithelium inside the mouse pancreas. Tissue-specific ablation of Cdc42 results in a fragmented pancreatic epithelia and large cellular aggregates that lack tubules (Figure 1 ). Using this in vivo model, the authors show that Cdc42 is required for establishing microlumens early during development of the pancreas and subsequently for maintaining the apical polarity of pancreatic tubules.
As pancreatic cells lacking Cdc42 form large aggregates with no lumen, the authors wondered whether this altered tissue structure affected cell specification, namely the lineage commitment of multipotent pancreatic progenitor cells. Based on genome-wide transcription factor expression analysis, previous work had identified a multipotent compartment at the tip of pancreatic branches containing progenitors that differentiate into exocrine, endocrine, and duct cells at different stages of organogenesis (Zhou et al., 2007) . So, without the correct branching structure in the Cdc42-ablated pancreas, would these progenitor cells differentiate properly? The authors report that ablating Cdc42 in the mouse pancreas not only disrupted the epithelial structure but also randomized the distribution of progenitors in the pancreas, increased the relative percentage of undifferentiated cells, and led to an increase in the number of progenitor cells differentiating into acinar cells at the expense of endocrine commitment. The authors reason that the increase in differentiation into the acinar lineage is due to misorganization of the extracellular matrix, and that the failure of Cdc42-ablated cells to commit to the endocrine lineage is perhaps due to disrupted Notch signaling in the mutant pancreas. These results demonstrate that epithelial structures are engineered under the guidance of Cdc42 and are required for the differentiation of pancreatic progenitor cells.
One striking result in the Kesavan et al. (2009) study is that a drug called Y27632, a Rho kinase (ROCK) inhibitor, restored tube formation in pancreatic epithelia lacking Cdc42. ROCK is a negative regulator of the Par3/Par6/ aPKC polarity complex, and Par3 phosphorylation by ROCK prevents its interaction with the complex. Inhibition of ROCK may rescue the tubulation defects in the Cdc42-ablated mouse pancreas by allowing activation of the Par3/Par6/aPKC complex, thus restoring correct polarity to the epithelia. However, a recent study suggested that Y27632 not only inhibits ROCK but also efficiently inhibits aPKC activity (Atwood and Prehoda, 2009) , which points to another interpretation. The rescue seen in Cdc42 mutants treated with Y27632 might be a combined effect of inhibiting both ROCK and aPKC activity. If so, why would the inhibition of ROCK upstream of aPKC, and the inhibition of aPKC downstream of ROCK, rescue the Cdc42 mutant phenotype? Further Tubes form in the developing mouse pancreas through expansion and fusion of existing microlumens. At embryonic day 11 and 12 (E11-E12), microlumens with visible apical surfaces (blue) form within the pancreas. At E12.5, these microlumens start to coalesce into tubular structures. This process requires activation of atypical protein kinase C (aPKC), a downstream effector of the master polarity protein, Cdc42. Between E12.5 and E15.5, lumenal structures, which are generated from the microlumens, coalesce and mature to form a single layer of polarized epithelium inside the mouse pancreas. Tissue-specific loss of Cdc42 results in fragmented pancreatic epithelia and large cellular aggregates that lack tubules. Furthermore, the failure to establish proper tissue structure in the pancreatic epithelia lacking Cdc42 causes the aberrant differentiation of pancreatic progenitor cells and interferes with cell specification in the developing pancreas. Adapted from Kesavan et al. (2009). experiments, especially to determine the activity status of aPKC, will hopefully solve this puzzle.
The Kesavan et al. (2009) study demonstrates how tubules form in the mouse pancreas and how Cdc42 controls polarization of epithelial tissues, which is required for this process. Most strikingly, Cdc42 controls the formation of the extracellular matrix, and the resulting microenvironment then determines cell fate. These results raise some questions about the function of Cdc42 and its regulation. Since the discovery of Cdc42 in 1990, numerous studies have shown that this "master polarity" protein plays essential roles in a variety of biological processes. The activity of Cdc42 depends on its nucleotide binding state: the GTP-bound Cdc42 is active, whereas the GDP-bound form is inactive. Families of GTPase-activating proteins (GAPs), guanine nucleotide exchange factors (GEFs), and guanine nucleotide dissociation inhibitors have been shown to regulate the activity of Cdc42. It is clear that these regulators do not affect just one small GTPase. Growing evidence suggests that GTPases can influence the activity of each other. For example, FilGAP is regulated by Rho to control Rac activity (Ohta et al., 2006) . In another case, Cool-2/a-Pix, a GEF, is a target of Cdc42 and activates Rac (Baird et al., 2005 ). It seems likely, then, that Cdc42 signaling is also highly connected to other small GTPase-signaling pathways. Furthermore, the function of Cdc42 is regulated not only by its activity status but also by its localization in the cell. Recent studies have suggested, for instance, that apical recruitment of active Cdc42 via phosphatidylinositol 4-5-bisphosphate controls lumen formation in epithelial tissues (MartinBelmonte et al., 2007) . Thus, a pressing research direction for the field of polarity is elucidating the plasticity of Cdc42, including the spatial-temporal activation of Cdc42 activity, activation-inactivation oscillations, and functional interactions with other small GTPases.
